Prognosis study in patients underwent electroconvulsive therapy (ECT)

Prognosis study in patients underwent electroconvulsive therapy (ECT) - Prognosis of patients underwent ECT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030458

Enrollment

100

Registered

2017-12-18

Start date

2016-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe or drug resistant major depressive disorder (MDD) with administration of initial electroconvulsive therapy (ECT)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients admitted to the Department of Psychiatry at the Shiga University of Medical Science Hospital between January 2009 and December 2011 whose diagnosis were met severe or drug registrant MDD criterion of DSM-IV-TR. Patients who chose an antidepressant therapy at the time point of the remission despite of giving explanation of all treatment options including the C/M-ECT for maintaining remission.

Exclusion criteria

Exclusion criteria: Patients diagnosed as the other axis I and II disorders and neurologic illnesses, and having a history of ECT.

Design outcomes

Primary

Measure	Time frame
Diagnostic change from MDD to bipolar disorder (BP) during the 3 years of followup period after receiving ECT	—

Secondary

Measure	Time frame
Relapse occurred during the 3 years of follow up period after receiving ECT Period until relapse of depression after receiving ECT Usage of remission maintenance therapy after receiving ECT	—

Countries

Japan

Contacts

Public ContactNaoki Kurimoto

Shiga University of Medical Science Hospital Department of Psychiatry

kurimoto@belle.shiga-med.ac.jp077-548-2111

Outcome results